Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBPB
2526
DELISTED
Potbelly
PBPB
| $1.06M | ﹤0.01% |
131,813
-1,860
| -1% | -$19.9K |
|
|
GPX
2527
DELISTED
GP Strategies Corp.
GPX
| $1.05M | ﹤0.01% |
83,557
-1,024
| -1% | -$14.6K |
|
2528
GDS Holdings
GDS
$6.56B
| $1.05M | ﹤0.01% |
45,468
-5,532
| -11% | -$144K |
|
2529
e.l.f. Beauty
ELF
$4.89B
| $1.04M | ﹤0.01% |
120,333
+8,492
| +8% | +$95.9K |
|
2530
Travelzoo
TZOO
$74.3M
| $1.04M | ﹤0.01% |
105,998
| – | – |
|
|
ROAN
2531
DELISTED
Roan Resources, Inc.
ROAN
| $1.04M | ﹤0.01% |
+123,701
| New | +$1.33M |
|
2532
Clear Channel Outdoor Holdings
CCO
$1.23B
| $1.04M | ﹤0.01% |
199,466
-11,599
| -5% | -$65.4K |
|
2533
Entravision Communication
EVC
$1.03B
| $1.04M | ﹤0.01% |
355,896
-316,595
| -47% | -$1.24M |
|
2534
Independent Bank Corp
IBCP
$787M
| $1.03M | ﹤0.01% |
49,055
+620
| +1% | +$14K |
|
2535
Crinetics Pharmaceuticals
CRNX
$8.84B
| $1.02M | ﹤0.01% |
33,874
-2,192
| -6% | -$61.7K |
|
2536
Arcus Biosciences
RCUS
$3.55B
| $1.01M | ﹤0.01% |
93,839
+43,092
| +85% | +$503K |
|
2537
Sonida Senior Living
SNDA
$1.91B
| $1M | ﹤0.01% |
9,848
+866
| +10% | +$108K |
|
2538
Weyco Group
WEYS
$372M
| $1M | ﹤0.01% |
34,356
-152
| -0.4% | -$4.83K |
|
|
RUBY
2539
DELISTED
Rubius Therapeutics, Inc
RUBY
| $996K | ﹤0.01% |
61,913
-740
| -1% | -$13.5K |
|
2540
Commercial Vehicle Group
CVGI
$154M
| $995K | ﹤0.01% |
174,411
+3,930
| +2% | +$27.2K |
|
|
UBX
2541
DELISTED
Unity Biotechnology
UBX
| $994K | ﹤0.01% |
6,113
+3,840
| +169% | +$510K |
|
|
UCFC
2542
DELISTED
United Community Financial Corp
UCFC
| $994K | ﹤0.01% |
112,257
| – | – |
|
2543
Viking Therapeutics
VKTX
$3.7B
| $989K | ﹤0.01% |
129,182
+17,800
| +16% | +$213K |
|
2544
Bristow Group
VTOL
$1.34B
| $988K | ﹤0.01% |
56,500
+613
| +1% | +$13.1K |
|
2545
Lennar Class B
LEN.B
$19.4B
| $983K | ﹤0.01% |
33,003
+1,090
| +3% | +$35.8K |
|
2546
Innovative Industrial Properties
IIPR
$1.71B
| $980K | ﹤0.01% |
21,575
+7,940
| +58% | +$364K |
|
|
XELA
2547
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $972K | ﹤0.01% |
21
| – | – |
|
|
ARA
2548
DELISTED
American Renal Associates Holdings, Inc
ARA
| $971K | ﹤0.01% |
84,207
-1,490
| -2% | -$25.4K |
|
2549
SI-BONE Inc
SIBN
$788M
| $967K | ﹤0.01% |
+46,268
| New | +$875K |
|
2550
Surgery Partners
SGRY
$2.01B
| $962K | ﹤0.01% |
98,195
-1,424
| -1% | -$19.1K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.